167 related articles for article (PubMed ID: 26393852)
1. Oxycodone for Cancer Pain in Adult Patients.
Schmidt-Hansen M; Bennett MI; Hilgart J
JAMA; 2015 Sep 22-29; 314(12):1282-3. PubMed ID: 26393852
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
BMJ Support Palliat Care; 2018 Jun; 8(2):117-128. PubMed ID: 29331953
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of oxycodone against cancer-related pain with a wide variety of pathophysiologies].
Sumitani M; Yamada Y
Gan To Kagaku Ryoho; 2011 Jun; 38(6):977-82. PubMed ID: 21677490
[TBL] [Abstract][Full Text] [Related]
4. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
5. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.
Reid CM; Martin RM; Sterne JA; Davies AN; Hanks GW
Arch Intern Med; 2006 Apr; 166(8):837-43. PubMed ID: 16636208
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of oxycodone in the management of cancer pain.
King SJ; Reid C; Forbes K; Hanks G
Palliat Med; 2011 Jul; 25(5):454-70. PubMed ID: 21708852
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of opioids in the treatment of chronic non-cancer pain.
Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
[TBL] [Abstract][Full Text] [Related]
9. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.
Riley J; Ross JR; Rutter D; Wells AU; Goller K; du Bois R; Welsh K
Support Care Cancer; 2006 Jan; 14(1):56-64. PubMed ID: 15952009
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain.
Nakajima N
Jpn J Clin Oncol; 2019 Dec; 49(11):1061-1064. PubMed ID: 31612910
[TBL] [Abstract][Full Text] [Related]
11. Oxycodone. Pharmacological profile and clinical data in chronic pain management.
Coluzzi F; Mattia C
Minerva Anestesiol; 2005; 71(7-8):451-60. PubMed ID: 16012419
[TBL] [Abstract][Full Text] [Related]
12. The use of oxycodone in cancer-related pain: a literature review.
Cairns R
Int J Palliat Nurs; 2001 Nov; 7(11):522-7. PubMed ID: 11775926
[TBL] [Abstract][Full Text] [Related]
13. [Three cases of cancer-related pain for which oxycodone injection was efficacious].
Shinozaki K; Nitta T; Yamauchi M; Doi M
Gan To Kagaku Ryoho; 2013 Jan; 40(1):119-23. PubMed ID: 23306933
[TBL] [Abstract][Full Text] [Related]
14. Oxycodone: a review of its use in the management of pain.
Riley J; Eisenberg E; Müller-Schwefe G; Drewes AM; Arendt-Nielsen L
Curr Med Res Opin; 2008 Jan; 24(1):175-92. PubMed ID: 18039433
[TBL] [Abstract][Full Text] [Related]
15. Oral Oxycodone for Acute Postoperative Pain: A Review of Clinical Trials.
Cheung CW; Ching Wong SS; Qiu Q; Wang X
Pain Physician; 2017 Feb; 20(2S):SE33-SE52. PubMed ID: 28226340
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study.
Sloan P; Slatkin N; Ahdieh H
Support Care Cancer; 2005 Jan; 13(1):57-65. PubMed ID: 15538638
[TBL] [Abstract][Full Text] [Related]
17. Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.
Naito T; Tashiro M; Ishida T; Ohnishi K; Kawakami J
J Clin Pharmacol; 2013 Aug; 53(8):812-8. PubMed ID: 23733622
[TBL] [Abstract][Full Text] [Related]
18. Prolonged-release oxycodone/naloxone in opioid-naïve patients - subgroup analysis of a prospective observational study.
Hesselbarth S; Hermanns K; Oepen P
Expert Opin Pharmacother; 2015 Mar; 16(4):457-64. PubMed ID: 25612469
[TBL] [Abstract][Full Text] [Related]
19. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
Takahashi Y; Iseki M
Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
